...
【24h】

Corticosteroids in the treatment of vestibular neuritis: a systematic review and meta-analysis.

机译:皮质类固醇激素治疗前庭神经炎的系统评价和荟萃分析。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: To systematically review and meta-analyze the results of all randomized controlled trials comparing corticosteroids with placebo for the treatment of patients with vestibular neuritis. DATA SOURCES: An electronic search was performed in MEDLINE, EMBASE, Cochrane Library, and CENTRAL databases, and then extensive hand-searching was performed for the identification of relevant studies. No time and language limitations were applied. STUDY SELECTION: Prospective randomized controlled trials comparing corticosteroids with placebo for the treatment of patients with vestibular neuritis. DATA EXTRACTION: Odds ratios (ORs), weighted mean differences (WMD), 95% confidence intervals (CIs), and tests for heterogeneity were reported. DATA SYNTHESIS: Four studies were eventually identified and systematically reviewed. Meta-analysis was feasible for 3 studies. Regarding the recovery of clinical symptoms, the proportion of patients with clinical recovery at 1 month after the initiation of therapy did not differ significantly between the corticosteroids and placebo groups (OR, 1.45; 95% CI, 0.26-8.01; p = 0.67). The proportion of patients with caloric complete recovery was significantly different between the corticosteroids and placebo groups both at 1 (OR, 12.64; 95% CI, 2.6-61.52; p = 0.002; heterogeneity, p = 0.53; fixed effects model) and 12 months (OR, 3.35; 95% CI, 1.45-7.76; p = 0.005; heterogeneity, p = 0.03; random effects model) after the initiation of therapy. The caloric extent of canal paresis at 12 months after the initiation of therapy seemed to differ significantly between patients who received corticosteroids and those who received placebo (WMD, -12.15; 95% CI, -19.85 to -4.46; p < 0.05; heterogeneity, p < 0.05; random effects model). CONCLUSION: The present systematic review and meta-analysis, based on the currently available evidence, suggests that corticosteroids improve only the caloric extent and recovery of canal paresis of patients with vestibular neuritis. At present, clinical recovery does not seem be better in patients receiving corticosteroids.
机译:目的:系统评价和比较所有比较皮质类固醇与安慰剂治疗前庭神经炎的随机对照试验的结果。数据来源:在MEDLINE,EMBASE,Cochrane图书馆和CENTRAL数据库中进行了电子搜索,然后进行了广泛的手工搜索以识别相关研究。没有时间和语言限制。研究选择:前瞻性随机对照试验比较了皮质类固醇与安慰剂治疗前庭神经炎的疗效。数据提取:报道了比值比(OR),加权均数差(WMD),95%置信区间(CI)和异质性测试。数据综合:最终确定并系统评价了四项研究。荟萃分析对3项研究是可行的。关于临床症状的恢复,开始治疗后1个月临床恢复的患者比例在皮质类固醇和安慰剂组之间没有显着差异(OR,1.45; 95%CI,0.26-8.01; p = 0.67)。皮质类固醇和安慰剂组之间的热量完全恢复患者比例在1时显着不同(OR为12.64; 95%CI为2.6-61.52; p = 0.002;异质性,p = 0.53;固定效应模型)和12个月(OR,3.35; 95%CI,1.45-7.76; p = 0.005;异质性,p = 0.03;随机效应模型)。接受皮质类固醇治疗的患者与接受安慰剂治疗的患者在开始治疗后12个月的管壁麻痹程度似乎有显着差异(WMD,-12.15; 95%CI,-19.85至-4.46; p <0.05;异质性, p <0.05;随机效应模型)。结论:基于目前可获得的证据,本系统的综述和荟萃分析表明,皮质类固醇激素仅能改善前庭神经炎患者的热量范围和管壁麻痹的恢复。目前,接受皮质类固醇激素治疗的患者的临床恢复似乎并不好。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号